Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular risk reduction.

Kai I Cheang1

  • 1Virginia Commonwealth University, School of Pharmacy, Richmond, VA 23298, USA. kicheang@vcu.edu

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Educational Outcomes Resulting From Restructuring a Scholarship Course for Doctor of Pharmacy Students.

American journal of pharmaceutical education·2019
Same author

Learning Activities to Build Population Health Management Skills for Pharmacy Students.

American journal of pharmaceutical education·2018
Same author

Raspberry Leaf and Hypoglycemia in Gestational Diabetes Mellitus.

Obstetrics and gynecology·2016
Same author

The role of variants regulating metformin transport and action in women with polycystic ovary syndrome.

Pharmacogenomics·2016
Same author

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome.

International journal of endocrinology·2016
Same author

Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.

Journal of women's health (2002)·2016
Same journal

Digging Deeper Into the Patient-Driven Payment Model.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Statins: The Burglar of Memory?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Identifying Cognitive Impairment in an Older Adult Using Two Different Screening Tools.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Management of Primary Sjögren's Syndrome.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Increased Use of Medical Marijuana: Skepticism vs. Evidence.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
See all related articles

This case study highlights managing multiple cardiovascular risks like dyslipidemia, hypertension, and diabetes. Patient education on asymptomatic chronic diseases is crucial for effective cardiovascular risk reduction.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Preventive Medicine

Background:

  • Cardiovascular disease remains a leading cause of morbidity and mortality worldwide.
  • Effective management requires addressing multiple interconnected risk factors.
  • Early identification and intervention are key to long-term patient outcomes.

Observation:

  • A clinical case involving a patient with dyslipidemia, hypertension, and diabetes is presented.
  • The case details the management of metabolic syndrome.
  • Testing for C-reactive protein as a cardiovascular marker is discussed.

Findings:

  • Integrated management of dyslipidemia, hypertension, and diabetes is essential for cardiovascular risk reduction.
  • Metabolic syndrome requires a comprehensive treatment approach.

Related Experiment Videos

  • C-reactive protein testing can provide additional prognostic information.

    • Implications:

    • Emphasizes the critical role of patient education in managing chronic, often asymptomatic, cardiovascular conditions.
    • Highlights the importance of a multi-faceted approach to cardiovascular risk management.
    • Suggests incorporating newer biomarkers like C-reactive protein into routine cardiovascular risk assessment.